Pegfilgrastim

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Use in leukaemia and myelodysplasia Limited clinical data suggest that the effect on time to recovery of severe neutropenia between pegfilgrastim and filgrastim is ...

  Pegfilgrastim

Patient Information Single-Dose Prefilled Syringe

PatientInformation Neulasta®(nu-las-tah) (pegfilgrastim) injection On-body injector for Neulasta What is the most important information I need to know about receiving Neulasta with the on-body injector for

  Pegfilgrastim

INJECTABLE MEDICATIONS FEE SCHEDULE ONCOLOGY …

code description max qty rate comments/notes injectable medications fee schedule oncology 01/01/2018 j9151 daunorubicin citrate, liposomal formulation

  Rates, Descriptions, Comments, Description max qty rate comments

ANAL CANCER - Jones & Bartlett Learning

1 A 5-Fluorouracil Mitomycin Radiation Therapy (Wayne State regimen).....2 5-Fluorouracil: 1000 mg/m2/day IV continuous infusion on days 1–4 and 29–32 Mitomycin: 15 mg/m2 IV on day 1 Radiation therapy: 200 cGy/day on days 1–5, 8–12, and 5–19 (total dose,

  Fluorouracil

OUR CLINICAL TRIALS - Amgen Oncology

*For more detailed information about the trial, visit www.clinicaltrials.gov or www.amgentrials.com. †The regulatory approval pathway for biosimilars requires study of a single indication and permits extrapolation to other reference indications with scientific justification.

FOR PHYSICIAN-ADMINISTERED PRODUCTS PATIENT …

PO Box 18769 Louisville, KY 40261-7821 Phone: (888) 762-6436 Fax: (866) 549-7239 www.safetynetfoundation.com

  Product, Patients, Physician, Administered, For physician administered products patient

BREAST CANCER TREATMENT REGIMENS (Part 1 of 6)

BREAST CANCER TREATMENT REGIMENS (Part 2 of 6) REGIMEN DOSING Adjuvant Therapy Without Concomitant Trastuzumab Tamoxifen1,8 Tamoxifen 20–40mg orally daily for no longer than 5 years (doses higher than 20mg should be divided into 2 doses, AM and PM).

  Treatment, Part, Breast, Cancer, Regimens, Breast cancer treatment regimens

HIGHLIGHTS OF PRESCRIBING INFORMATION NEULASTA …

3 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Patients with CancerReceiving Myelosuppressive Chemotherapy Neulasta is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with